{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:33:25Z","timestamp":1792978405586,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12282-026-01913-9","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:46:44Z","timestamp":1790315204000},"page":"1329-1339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical impact of ENIGMA-based variant reclassification on genotype\u2013phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-6983","authenticated-orcid":false,"given":"Said Furkan","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6652-0290","authenticated-orcid":false,"given":"Pervin","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-1122","authenticated-orcid":false,"given":"Hakan","family":"Kosku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-8948","authenticated-orcid":false,"given":"Bulent","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4938-3420","authenticated-orcid":false,"given":"Ahmet Cevdet","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"1","key":"1913_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13073-019-0691-1","volume":"12","author":"NS Abul-Husn","year":"2019","unstructured":"Abul-Husn NS, Soper ER, Odgis JA, Cullina S, Bobo D, Moscati A, et al. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank. Genome Med. 2019;12(1):2.","journal-title":"Genome Med"},{"issue":"4","key":"1913_CR2","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ijc.32176","volume":"145","author":"SP Bhaskaran","year":"2019","unstructured":"Bhaskaran SP, Chandratre K, Gupta H, Zhang L, Wang X, Cui J, et al. Germline variation in BRCA1\/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients. Int J Cancer. 2019;145(4):962\u201373.","journal-title":"Int J Cancer"},{"issue":"2","key":"1913_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10552-022-01648-w","volume":"34","author":"N Abdallah","year":"2023","unstructured":"Abdallah N, Purrington KS, Tatineni S, Assad H, Petrucelli N, Simon MS. Racial and ethnic variation in BRCA1 and BRCA2 genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center. Cancer Causes Control. 2023;34(2):141\u20139.","journal-title":"Cancer Causes Control"},{"issue":"5","key":"1913_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/humu.23406","volume":"39","author":"TR Rebbeck","year":"2018","unstructured":"Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, et al. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat. 2018;39(5):593\u2013620.","journal-title":"Hum Mutat"},{"issue":"1","key":"1913_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA). Cancer Epidemiol Biomarkers Prev. 2012;21(1):134\u201347.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"1913_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313(13):1347\u201361.","journal-title":"JAMA"},{"issue":"1","key":"1913_CR7","first-page":"14","volume":"3","author":"SM Wang","year":"2023","unstructured":"Wang SM. A global perspective on the ethnic-specific BRCA variation and its implication in clinical application. J Natl Cancer Cent. 2023;3(1):14\u201320.","journal-title":"J Natl Cancer Cent"},{"issue":"7","key":"1913_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMsa1507092","volume":"375","author":"AK Manrai","year":"2016","unstructured":"Manrai AK, Funke BH, Rehm HL, Olesen MS, Maron BA, Szolovits P, et al. Genetic Misdiagnoses and the Potential for Health Disparities. N Engl J Med. 2016;375(7):655\u201365.","journal-title":"N Engl J Med"},{"issue":"1","key":"1913_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13045-020-01010-0","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang H, Wang X, Liu J, Li J, Wang X, et al. Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort. J Hematol Oncol. 2021;14(1):18.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"1913_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"key":"1913_CR11","doi-asserted-by":"publisher","first-page":"101961","DOI":"10.1016\/j.gimo.2024.101961","volume":"3","author":"A Benet-Pages","year":"2025","unstructured":"Benet-Pages A, Laner A, Nassar LR, Wohlfrom T, Steinke-Lange V, Haeussler M, et al. Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1\/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG\/AMP classification system. Genet Med Open. 2025;3:101961.","journal-title":"Genet Med Open"},{"issue":"5","key":"1913_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/jmg-2023-109694","volume":"61","author":"G Innella","year":"2024","unstructured":"Innella G, Ferrari S, Miccoli S, Luppi E, Fortuno C, Parsons MT, et al. Clinical implications of VUS reclassification in a single-centre series from application of ACMG\/AMP classification rules specified for BRCA1\/2. J Med Genet. 2024;61(5):483\u20139.","journal-title":"J Med Genet"},{"issue":"9","key":"1913_CR13","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ajhg.2024.07.013","volume":"111","author":"MT Parsons","year":"2024","unstructured":"Parsons MT, de la Hoya M, Richardson ME, Tudini E, Anderson M, Berkofsky-Fessler W, et al. Evidence-based recommendations for gene-specific ACMG\/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel. Am J Hum Genet. 2024;111(9):2044\u201358.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1913_CR14","first-page":"564","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS Recommendations Description Seq Variants: 2016 Update Hum Mutat. 2016;37(6):564\u20139.","journal-title":"HGVS Recommendations Description Seq Variants: 2016 Update Hum Mutat"},{"key":"1913_CR15","doi-asserted-by":"crossref","unstructured":"Pleasant V, Boggan J, Richards B, Milliron KJ, Purrington KS, Simon M et al. Reclassification of variants of uncertain significance by race, ethnicity, and ancestry for patients at risk for breast cancer. Front Oncol. 2025;15","DOI":"10.3389\/fonc.2025.1455509"},{"issue":"10","key":"1913_CR16","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer. 2009;115(10):2222\u201333.","journal-title":"Cancer"},{"issue":"3","key":"1913_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10549-017-4198-4","volume":"163","author":"J Krammer","year":"2017","unstructured":"Krammer J, Pinker-Domenig K, Robson ME, Gonen M, Bernard-Davila B, Morris EA, et al. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2017;163(3):565\u201371.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1913_CR18","doi-asserted-by":"publisher","first-page":"7073","DOI":"10.1038\/s41598-020-63759-1","volume":"10","author":"S De Talhouet","year":"2020","unstructured":"De Talhouet S, Peron J, Vuilleumier A, Friedlaender A, Viassolo V, Ayme A, et al. Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes. Sci Rep. 2020;10(1):7073.","journal-title":"Sci Rep"},{"issue":"12","key":"1913_CR19","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/s41416-023-02263-5","volume":"128","author":"DG O\u2019Mahony","year":"2023","unstructured":"O\u2019Mahony DG, Ramus SJ, Southey MC, Meagher NS, Hadjisavvas A, John EM, et al. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2. Br J Cancer. 2023;128(12):2283\u201394.","journal-title":"Br J Cancer"},{"key":"1913_CR20","doi-asserted-by":"publisher","first-page":"787143","DOI":"10.1155\/2014\/787143","volume":"2014","author":"G Girolimetti","year":"2014","unstructured":"Girolimetti G, Perrone AM, Santini D, Barbieri E, Guerra F, Ferrari S, et al. BRCA-associated ovarian cancer: from molecular genetics to risk management. Biomed Res Int. 2014;2014:787143.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1913_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13073-022-01052-8","volume":"14","author":"L Dorling","year":"2022","unstructured":"Dorling L, Carvalho S, Allen J, Parsons MT, Fortuno C, Gonzalez-Neira A, et al. Breast cancer risks associated with missense variants in breast cancer susceptibility genes. Genome Med. 2022;14(1):51.","journal-title":"Genome Med"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01913-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01913-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01913-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:03:23Z","timestamp":1792976603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01913-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01913-9","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Commitee of Ankara Bilkent City Hospital (TABED 1\/1555\/2025). Due to the retrospective nature of the study, the requirement for informed consent was waived. All procedures were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}